Literature DB >> 29399110

MicroRNA-370 suppresses the progression and proliferation of human astrocytoma and glioblastoma by negatively regulating β-catenin and causing activation of FOXO3a.

Ming Lu1, Yong Wang2, Shizhen Zhou2, Jun Xu2, Jing Li2, Rongjie Tao2, Yufang Zhu2.   

Abstract

Certain microRNAs (miRs) regulate the progression and metastasis of various cancer types. In the present study, the role of miR-370 in the progression and proliferation of human astrocytoma and glioblastoma cells was assessed and the underlying molecular mechanism was investigated. miR-370 levels in clinical specimens of human glioma and peritumoral tissues were determined by reverse-transcription quantitative PCR. Oligonucleotide mimics and inhibitors were transfected into the U-251MG human astrocytoma cell line and the and U-87MG glioblastoma cell line and the cell viability of was determined by an MTT assay. The expression of β-catenin and forkhead box protein (FOX)O3a was determined by western blot analysis. The results revealed that the expression of miR-370 in human glioma tissues was significantly decreased compared with that in peritumoral tissues. The miR-370 levels in patients with grade III/IV gliomas were significantly decreased compared with those in grade I/II. Transfection with miR-370 mimics inhibited the proliferation of U-251MG and U-87MG cells. Furthermore, the miR-370 levels were negatively correlated with β-catenin and positively correlated with nuclear FOXO3a. In conclusion, miR-370 inhibited the proliferation of human glioma cells by regulating the levels of β-catenin and the activation of FOXO3a, suggesting that miR-370 was a tumor suppressor in the progression of human astrocytoma and glioblastoma cells.

Entities:  

Keywords:  forkhead box protein O3a; gliomas; microRNA-370; β-catenin

Year:  2017        PMID: 29399110      PMCID: PMC5772906          DOI: 10.3892/etm.2017.5494

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  29 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Mitochondrial miRNA (MitomiR): a new player in cardiovascular health.

Authors:  Hemalatha Srinivasan; Samarjit Das
Journal:  Can J Physiol Pharmacol       Date:  2015-03-18       Impact factor: 2.273

3.  Origin of the U87MG glioma cell line: Good news and bad news.

Authors:  Marie Allen; Mia Bjerke; Hanna Edlund; Sven Nelander; Bengt Westermark
Journal:  Sci Transl Med       Date:  2016-08-31       Impact factor: 17.956

Review 4.  Heterogeneity of histopathological presentation of pilocytic astrocytoma - diagnostic pitfalls. A review.

Authors:  E Matyja; W Grajkowska; K Stępień; E Naganska
Journal:  Folia Neuropathol       Date:  2016       Impact factor: 2.038

5.  Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis resistance in glioma cells.

Authors:  Hongyu Guan; Libing Song; Junchao Cai; Yongbo Huang; Jueheng Wu; Jie Yuan; Jun Li; Mengfeng Li
Journal:  PLoS One       Date:  2011-05-18       Impact factor: 3.240

6.  From the Cover: Autophagy Induction Contributes to Cadmium Toxicity in Mesenchymal Stem Cells via AMPK/FOXO3a/BECN1 Signaling.

Authors:  Min Yang; Huifeng Pi; Min Li; Shangcheng Xu; Lei Zhang; Jia Xie; Li Tian; Manyu Tu; Mindi He; Yonghui Lu; Zhengping Yu; Zhou Zhou
Journal:  Toxicol Sci       Date:  2016-08-04       Impact factor: 4.849

7.  An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection.

Authors:  Abraham Shaked; Bao-Li Chang; Michael R Barnes; Peter Sayre; Yun R Li; Smita Asare; Michele DesMarais; Michael V Holmes; Toumy Guettouche; Brendan J Keating
Journal:  Hepatology       Date:  2016-10-05       Impact factor: 17.425

8.  The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia.

Authors:  Xiaolu Zhang; Jiping Zeng; Minran Zhou; Bingnan Li; Yuanyuan Zhang; Tao Huang; Lixiang Wang; Jihui Jia; Chunyan Chen
Journal:  Mol Cancer       Date:  2012-08-17       Impact factor: 27.401

9.  Expression of microRNA-370 in human breast cancer compare with normal samples.

Authors:  Halimeh Mollainezhad; Nahid Eskandari; Abbasali Pourazar; Mansoor Salehi; Alireza Andalib
Journal:  Adv Biomed Res       Date:  2016-07-29

Review 10.  A systematic review and meta-analysis of gene therapy in animal models of cerebral glioma: why did promise not translate to human therapy?

Authors:  T C Hirst; H M Vesterinen; S Conlin; K J Egan; A Antonic; A Lawson McLean; M R Macleod; R Grant; P M Brennan; E S Sena; I R Whittle
Journal:  Evid Based Preclin Med       Date:  2015-01-20
View more
  7 in total

1.  LncRNA PVT1 Facilitates Tumorigenesis and Progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway.

Authors:  Chao Fu; Dongyuan Li; Xiaonan Zhang; Naijie Liu; Guonan Chi; Xingyi Jin
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

2.  MicroRNA-370 functions as a tumor suppressor in hepatocellular carcinoma via inhibition of the MAPK/JNK signaling pathway by targeting BEX2.

Authors:  Xin Wang; Wenyan Zhu; Chuanshen Xu; Feng Wang; Xiaodan Zhu; Yandong Sun; Yuan Guo; Xiaoyue Fu; Yong Zhang; Yunjin Zang
Journal:  J Hum Genet       Date:  2019-09-17       Impact factor: 3.172

3.  Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.

Authors:  Valentina Lulli; Mariachiara Buccarelli; Ramona Ilari; Giorgia Castellani; Chiara De Dominicis; Alessandra Di Giamberardino; Quintino Giorgio D Alessandris; Stefano Giannetti; Maurizio Martini; Vittorio Stumpo; Alessandra Boe; Gabriele De Luca; Mauro Biffoni; Giovanna Marziali; Roberto Pallini; Lucia Ricci-Vitiani
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

Review 4.  Non-coding RNAs and glioblastoma: Insight into their roles in metastasis.

Authors:  Seyed Mojtaba Mousavi; Maryam Derakhshan; Fatereh Baharloii; Fatemeh Dashti; Seyed Mohammad Ali Mirazimi; Maryam Mahjoubin-Tehran; Saereh Hosseindoost; Pouya Goleij; Neda Rahimian; Michael R Hamblin; Hamed Mirzaei
Journal:  Mol Ther Oncolytics       Date:  2021-12-22       Impact factor: 7.200

5.  Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.

Authors:  Xiaoming Zhang; Wanxiang Niu; Maolin Mu; Shanshan Hu; Chaoshi Niu
Journal:  J Exp Clin Cancer Res       Date:  2020-09-22

Review 6.  Targeting Non-coding RNA for Glioblastoma Therapy: The Challenge of Overcomes the Blood-Brain Barrier.

Authors:  Rohit K Sharma; Carlos Calderon; Pablo E Vivas-Mejia
Journal:  Front Med Technol       Date:  2021-08-10

7.  miRNA-204-5p acts as tumor suppressor to influence the invasion and migration of astrocytoma by targeting ezrin and is downregulated by DNA methylation.

Authors:  Haibo Jiang; Ruixiang Ge; Siwen Chen; Laiquan Huang; Jie Mao; Lili Sheng
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.